175 related articles for article (PubMed ID: 33440385)
21. Type I interferons for induction of remission in ulcerative colitis.
Seow CH; Benchimol EI; Griffiths AM; Steinhart AH
Cochrane Database Syst Rev; 2008 Jul; (3):CD006790. PubMed ID: 18646167
[TBL] [Abstract][Full Text] [Related]
22. Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Marshall JK; Thabane M; Steinhart AH; Newman JR; Anand A; Irvine EJ
Cochrane Database Syst Rev; 2012 Nov; 11():CD004118. PubMed ID: 23152224
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate for maintenance of remission in ulcerative colitis.
Wang Y; MacDonald JK; Vandermeer B; Griffiths AM; El-Matary W
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007560. PubMed ID: 26263042
[TBL] [Abstract][Full Text] [Related]
24. Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis.
Stremmel W; Merle U; Zahn A; Autschbach F; Hinz U; Ehehalt R
Gut; 2005 Jul; 54(7):966-71. PubMed ID: 15951544
[TBL] [Abstract][Full Text] [Related]
25. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.
Haifer C; Paramsothy S; Kaakoush NO; Saikal A; Ghaly S; Yang T; Luu LDW; Borody TJ; Leong RW
Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):141-151. PubMed ID: 34863330
[TBL] [Abstract][Full Text] [Related]
26. Probiotics for maintenance of remission in ulcerative colitis.
Iheozor-Ejiofor Z; Kaur L; Gordon M; Baines PA; Sinopoulou V; Akobeng AK
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD007443. PubMed ID: 32128794
[TBL] [Abstract][Full Text] [Related]
27. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Sutherland L; Macdonald JK
Cochrane Database Syst Rev; 2006 Apr; (2):CD000544. PubMed ID: 16625537
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of prolonged release budesonide granules in mesalazine-refractory ulcerative colitis: A multi-centre Phase IIa study (TOPICAL-1).
Fellermann K; Schiefke I; Rácz I; Derova J; Jonaitis L; Wehrum S; Nacak T; Greinwald R
United European Gastroenterol J; 2020 Dec; 8(10):1186-1195. PubMed ID: 33028169
[TBL] [Abstract][Full Text] [Related]
29. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Sutherland L; Macdonald JK
Cochrane Database Syst Rev; 2006 Apr; (2):CD000543. PubMed ID: 16625536
[TBL] [Abstract][Full Text] [Related]
30. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
Chande N; Wang Y; McDonald JW; MacDonald JK
Cochrane Database Syst Rev; 2015 Aug; 8(8):CD006774. PubMed ID: 35658167
[TBL] [Abstract][Full Text] [Related]
31. Probiotics for maintenance of remission in ulcerative colitis.
Naidoo K; Gordon M; Fagbemi AO; Thomas AG; Akobeng AK
Cochrane Database Syst Rev; 2011 Dec; (12):CD007443. PubMed ID: 22161412
[TBL] [Abstract][Full Text] [Related]
32. Cannabis for the treatment of ulcerative colitis.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
[TBL] [Abstract][Full Text] [Related]
33. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Timmer A; Patton PH; Chande N; McDonald JW; MacDonald JK
Cochrane Database Syst Rev; 2016 May; 2016(5):CD000478. PubMed ID: 27192092
[TBL] [Abstract][Full Text] [Related]
34. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
Cohen RD; Woseth DM; Thisted RA; Hanauer SB
Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
[TBL] [Abstract][Full Text] [Related]
35. Oral delayed-release mesalazine: a review of its use in ulcerative colitis and Crohn's disease.
Prakash A; Markham A
Drugs; 1999 Mar; 57(3):383-408. PubMed ID: 10193690
[TBL] [Abstract][Full Text] [Related]
36. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Murray A; Nguyen TM; Parker CE; Feagan BG; MacDonald JK
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD000544. PubMed ID: 32856298
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporine A for induction of remission in severe ulcerative colitis.
Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K
Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937
[TBL] [Abstract][Full Text] [Related]
38. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.
Lawson MM; Thomas AG; Akobeng AK
Cochrane Database Syst Rev; 2006 Jul; (3):CD005112. PubMed ID: 16856078
[TBL] [Abstract][Full Text] [Related]
39. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Timmer A; McDonald JW; Tsoulis DJ; Macdonald JK
Cochrane Database Syst Rev; 2012 Sep; (9):CD000478. PubMed ID: 22972046
[TBL] [Abstract][Full Text] [Related]
40. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
Rubin DT; Dotan I; DuVall A; Bouhnik Y; Radford-Smith G; Higgins PDR; Mishkin DS; Arrisi P; Scalori A; Oh YS; Tole S; Chai A; Chamberlain-James K; Lacey S; McBride J; Panés J;
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):17-27. PubMed ID: 34798036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]